Page last updated: 2024-08-17

levodopa and Weight Loss

levodopa has been researched along with Weight Loss in 19 studies

Research

Studies (19)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (10.53)	18.2507
2000's	6 (31.58)	29.6817
2010's	9 (47.37)	24.3611
2020's	2 (10.53)	2.80

Authors

Authors	Studies
Antonini, A; Biundo, R; Calandrella, D; Carecchio, M; Carrer, T; Del Sorbo, F; Farinati, F; Garrì, F; Mainardi, M; Pezzoli, G; Pistonesi, F; Russo, FP; Sandre, M; Savarino, E; Soliveri, P; Weis, L; Zecchinelli, AL	1
Artaud, F; Corvol, JC; Elbaz, A; Lee, PC; Mangone, G; Vidailhet, M	1
Eerola-Rautio, J; Kenttämies, A; Kylänpää, L; Lindström, O; Lyytinen, J; Pekkonen, E; Udd, M	1
Benesh, J; Boyd, JT; Chatamra, K; Eaton, S; Espay, AJ; Facheris, MF; Fernandez, HH; Fung, VSC; Hall, C; Lew, MF; Robieson, WZ; Rodriguez, RL; Slevin, JT; Standaert, DG; Vanagunas, AD; Zadikoff, C	1
Beccaria, L; Fabbri, M; Ferreira, JJ; Lopiano, L; Merola, A; Montanaro, E; Palermo, S; Romagnolo, A; Zibetti, M	1
Ehlen, F; Jugel, C; Klostermann, F; Marzinzik, F; Müller, T; Taskin, B	1
Sharma, JC; Vassallo, M	1
Avolio, C; De Francesco, V; Lalla, A; Martino, T; Melchionda, D; Specchio, LM; Tonti, P	1
Granérus, AK; Lorefält, B; Toss, G	1
Bachmann, CG; Brunner, E; Trenkwalder, C; Zapf, A	1
Hazan, D; Siegert, S; Szyper-Kravitz, M	1
Barichella, M; Cancello, R; Cassani, E; Faillace, G; Moise, G; Pezzoli, G; Privitera, G; Zecchinelli, A; Zulian, A	1
Barichella, M; Caccialanza, R; Cancello, R; Cassani, E; Cereda, E; Iorio, L; Madio, C; Pezzoli, G; Pusani, C	1
Borowik, H; Drozdowski, W; Kułakowska, A; Pogorzelski, R	1
Carlsson, M; Ganowiak, W; Granérus, AK; Lorefält, B; Pålhagen, S; Toss, G; Unosson, M	1
Hasoon, M; Macnamara, L; Ross, I; Sharma, JC; Vassallo, M	1
Durrieu, G; LLau, ME; Montastruc, JL; Rascol, A; Rascol, O; Senard, JM	1
Inoue, S; Nakamura, S; Numata, K; Okazaki, H; Takamura, Y; Tanaka, K	1

Reviews

1 review(s) available for levodopa and Weight Loss

Article	Year
Prognostic significance of weight changes in Parkinson's disease: the Park-weight phenotype. Neurodegenerative disease management, 2014, Volume: 4, Issue:4 Topics: Antiparkinson Agents; Body Weight; Dyskinesia, Drug-Induced; Energy Intake; Female; Humans; Levodopa; Male; Nutritional Status; Parkinson Disease; Quality of Life; Sex Factors; Smell; Thinness; Treatment Outcome; Weight Loss	2014

Trials

3 trial(s) available for levodopa and Weight Loss

Article	Year
Long-term safety and efficacy of levodopa-carbidopa intestinal gel in advanced Parkinson's disease. Movement disorders : official journal of the Movement Disorder Society, 2018, Volume: 33, Issue:6 Topics: Adult; Aged; Aged, 80 and over; Antiparkinson Agents; Carbidopa; Compulsive Behavior; Double-Blind Method; Drug Combinations; Female; Gels; Humans; International Cooperation; Intestines; Levodopa; Longitudinal Studies; Male; Middle Aged; Outcome Assessment, Health Care; Parkinson Disease; Polyneuropathies; Weight Loss	2018
A randomized placebo-controlled trial of rasagiline in levodopa-treated patients with Parkinson disease and motor fluctuations: the PRESTO study. Archives of neurology, 2005, Volume: 62, Issue:2 Topics: Aged; Aged, 80 and over; Anorexia; Antiparkinson Agents; Dose-Response Relationship, Drug; Double-Blind Method; Female; Follow-Up Studies; Humans; Indans; Levodopa; Male; Middle Aged; Monoamine Oxidase Inhibitors; Motor Activity; Parkinson Disease; Retrospective Studies; Severity of Illness Index; Time Factors; Treatment Outcome; Vomiting; Weight Loss	2005
Cascade of levodopa dose and weight-related dyskinesia in Parkinson's disease (LD-WD-PD cascade). Parkinsonism & related disorders, 2006, Volume: 12, Issue:8 Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Cohort Studies; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Female; Humans; Levodopa; Logistic Models; Male; Parkinson Disease; Retrospective Studies; Risk Factors; Sex Factors; Weight Loss	2006

Other Studies

15 other study(ies) available for levodopa and Weight Loss

Article	Year
Long-term safety, discontinuation and mortality in an Italian cohort with advanced Parkinson's disease on levodopa/carbidopa intestinal gel infusion. Journal of neurology, 2022, Volume: 269, Issue:10 Topics: Antiparkinson Agents; Carbidopa; Drug Combinations; Gels; Humans; Levodopa; Parkinson Disease; Retrospective Studies; Weight Loss	2022
Longitudinal association between dopamine agonists and weight in Parkinson's disease. Parkinsonism & related disorders, 2020, Volume: 80 Topics: Aged; Antiparkinson Agents; Body Mass Index; Compulsive Behavior; Dopamine Agonists; Feeding and Eating Disorders; Female; Humans; Levodopa; Longitudinal Studies; Male; Middle Aged; Parkinson Disease; Weight Gain; Weight Loss	2020
Problems related to levodopa-carbidopa intestinal gel treatment in advanced Parkinson's disease. Brain and behavior, 2017, Volume: 7, Issue:7 Topics: Aged; Antiparkinson Agents; Carbidopa; Drug Combinations; Female; Gels; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Retrospective Studies; Treatment Outcome; Weight Loss	2017
Levodopa/carbidopa intestinal gel infusion and weight loss in Parkinson's disease. European journal of neurology, 2019, Volume: 26, Issue:3 Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Carbidopa; Drug Combinations; Female; Gels; Humans; Infusions, Parenteral; Levodopa; Male; Middle Aged; Parkinson Disease; Weight Loss	2019
Neuropathy in Parkinson's disease patients with intestinal levodopa infusion versus oral drugs. PloS one, 2013, Volume: 8, Issue:6 Topics: Administration, Oral; Aged; Antiparkinson Agents; Carbidopa; Dose-Response Relationship, Drug; Female; Gels; Humans; Infusions, Parenteral; Intestines; Levodopa; Male; Middle Aged; Patient Outcome Assessment; Polyneuropathies; Prospective Studies; Weight Loss	2013
Weight loss and decubitus duodenal ulcer in Parkinson's disease treated with levodopa-carbidopa intestinal gel infusion. Journal of neural transmission (Vienna, Austria : 1996), 2016, Volume: 123, Issue:12 Topics: Aged; Antiparkinson Agents; Carbidopa; Drug Combinations; Duodenal Ulcer; Duodenum; Dyskinesias; Endoscopes, Gastrointestinal; Humans; Levodopa; Male; Parkinson Disease; Tomography, X-Ray Computed; Weight Loss	2016
Weight loss, body fat mass, and leptin in Parkinson's disease. Movement disorders : official journal of the Movement Disorder Society, 2009, Apr-30, Volume: 24, Issue:6 Topics: Absorptiometry, Photon; Adipose Tissue; Aged; Antiparkinson Agents; Female; Follow-Up Studies; Humans; Leptin; Levodopa; Male; Middle Aged; Parkinson Disease; Radioimmunoassay; Sex Factors; Statistics, Nonparametric; Weight Loss	2009
Dopaminergic treatment is associated with decreased body weight in patients with Parkinson's disease and dyskinesias. European journal of neurology, 2009, Volume: 16, Issue:8 Topics: Age of Onset; Aged; Antiparkinson Agents; Body Mass Index; Body Weight; Dopamine Agents; Dyskinesias; Eating; Female; Follow-Up Studies; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Psychomotor Performance; Severity of Illness Index; Time Factors; Weight Loss	2009
Severe weight loss in a young Parkinson's disease patient: a multidisciplinary approach to diagnosis and treatment. The Israel Medical Association journal : IMAJ, 2011, Volume: 13, Issue:3 Topics: Antiparkinson Agents; Carbidopa; Caregivers; Disease Progression; Domestic Violence; Drug Combinations; Eating; Female; Humans; Hypertrichosis; Levodopa; Middle Aged; Nutritional Status; Parkinson Disease; Weight Loss	2011
The sleeve gastrectomy intervention to treat morbid obesity in a Parkinson's disease patient. Clinical nutrition (Edinburgh, Scotland), 2013, Volume: 32, Issue:3 Topics: Bariatric Surgery; Body Mass Index; Female; Gastrectomy; Humans; Levodopa; Middle Aged; Obesity, Morbid; Parkinson Disease; Treatment Outcome; Weight Loss	2013
Nutritional risk and gastrointestinal dysautonomia symptoms in Parkinson's disease outpatients hospitalised on a scheduled basis. The British journal of nutrition, 2013, Jul-28, Volume: 110, Issue:2 Topics: Aged; Confidence Intervals; Constipation; Deglutition Disorders; Female; Gastrointestinal Diseases; Hospitalization; Humans; Levodopa; Male; Malnutrition; Middle Aged; Nutritional Status; Odds Ratio; Outpatients; Parkinson Disease; Prevalence; Primary Dysautonomias; Risk Factors; Severity of Illness Index; Sialorrhea; Weight Loss	2013
[Wearing off phenomenon presenting with features of paroxysmal abdominal pain]. Neurologia i neurochirurgia polska, 2003, Volume: 37 Suppl 5 Topics: Abdominal Pain; Aged; Antiparkinson Agents; Female; Gastrointestinal Motility; Humans; Levodopa; Parkinson Disease; Wasting Syndrome; Weight Loss	2003
Does L-dopa treatment contribute to reduction in body weight in elderly patients with Parkinson's disease? Acta neurologica Scandinavica, 2005, Volume: 111, Issue:1 Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Deglutition Disorders; Female; Follow-Up Studies; Humans; Levodopa; Male; Motor Activity; Movement Disorders; Nausea; Parkinson Disease; Smell; Weight Loss	2005
Parkinson's disease and weight loss: a study with anthropometric and nutritional assessment. Clinical autonomic research : official journal of the Clinical Autonomic Research Society, 1992, Volume: 2, Issue:3 Topics: Aged; Anthropometry; Body Composition; Bromocriptine; Female; Humans; Levodopa; Male; Middle Aged; Nutrition Assessment; Parkinson Disease; Reference Values; Sex Characteristics; Weight Loss	1992
Very-low-calorie diet-induced weight reduction reverses impaired growth hormone secretion response to growth hormone-releasing hormone, arginine, and L-dopa in obesity. Metabolism: clinical and experimental, 1990, Volume: 39, Issue:9 Topics: Adolescent; Adult; Arginine; Body Weight; Diet, Reducing; Female; Growth Hormone; Growth Hormone-Releasing Hormone; Humans; Levodopa; Male; Obesity; Weight Loss	1990